Crinetics Pharmaceuticals CRNX
NASDAQ CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Finished Goods (2025 - 2026)

Crinetics Pharmaceuticals (CRNX) posted quarterly Finished Goods of $29000.0 for Q1 2026, up 61.11% quarter-over-quarter from $18000.0 in Q4 2025.

Analysis

Crinetics Pharmaceuticals (CRNX) Finished Goods (2025 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Finished Goods history runs 2 years deep, the most recent figure standing at $29000.0 for Q1 2026.

  • In Q1 2026, Finished Goods changed N/A year-over-year to $29000.0; the TTM figure through Mar 2026 stood at $29000.0 (changed N/A YoY), while the FY2025 annual figure was $18000.0, changed N/A from the prior year.
  • Finished Goods for Q1 2026 stood at $29000.0, up from $18000.0 in the prior quarter.
  • The five-year high for Finished Goods was $29000.0 in Q1 2026, with the low at $18000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 903,000.00
Mar 31, 2026 29,000.00
Dec 31, 2025 18,000.00